Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M52.5Revenue $M31.9Net Margin (%)--Altman Z-Score4.0
Enterprise Value $M47.6EPS $-0.3Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yY
Price/Book1.010-y EBITDA Growth Rate %--Quick Ratio14.5Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio14.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-29.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-32.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M54.7ROIC % (ttm)-61.7Gross Margin Increase y-yN

Gurus Latest Trades with BLRX

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BLRX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BLRX: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about BLRX:

    News about BLRX:

    Articles On GuruFocus.com
    Analysts Positive on BioLineRx Ltd. Following Ph2 Testing Expansion for AML May 05 2015 
    Roth Capital Weighs In On 5 Biotech Stocks to Watch Apr 05 2015 

    More From Other Websites
    BioLineRx to Present at 2016 BIO CEO & Investor Conference in New York on February 8 Feb 01 2016
    BioLineRx to Present at 2016 BIO CEO & Investor Conference in New York on February 8 Feb 01 2016
    BioLineRx Receives Confirmation of Medical Device Classification in Europe for Celiac Treatment Jan 25 2016
    BioLineRx Receives Confirmation of Medical Device Classification in Europe for Celiac Treatment Jan 25 2016
    Merck, BioLineRX to study drug combo to fight pancreatic cancer Jan 12 2016
    BioLineRx Announces Collaboration with MSD to Investigate the Combination of KEYTRUDA... Jan 12 2016
    BioLineRx Announces Collaboration with MSD to Investigate the Combination of KEYTRUDA... Jan 12 2016
    BioLineRx to Present at Biotech Showcase 2016 Conference in San Francisco Jan 04 2016
    BioLineRx to Present at Biotech Showcase 2016 Conference in San Francisco Jan 04 2016
    BioLineRx Announces Regulatory Submission for Phase 2 Trial of BL-8040 as Novel Stem Cell... Dec 14 2015
    BioLineRx Announces Regulatory Submission for Phase 2 Trial of BL-8040 as Novel Stem Cell... Dec 14 2015
    BIOLINERX LTD. Financials Dec 08 2015
    Bioline RX (BLRX) Shares March Higher, Can It Continue? Dec 04 2015
    BioLineRx Establishes Oncology Scientific Advisory Board Dec 03 2015
    BioLineRx Establishes Oncology Scientific Advisory Board Dec 03 2015
    BioLineRx (BLRX) Worth Watching: Stock Rises 11.3% Dec 02 2015
    Hedge Funds Are Selling Bioline RX Ltd (BLRX) Nov 26 2015
    BioLineRx Ltd. to Host Investor Breakfast in New York on December 3, 2015 Nov 25 2015
    BioLineRx Ltd. to Host Investor Breakfast in New York on December 3, 2015 Nov 25 2015
    BioLineRx to Present at the LD Micro Main Event Nov 24 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK